{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:33:06Z","timestamp":1770982386594,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Danish Ministry for Social Affairs and the Interior","award":["9173-0003"],"award-info":[{"award-number":["9173-0003"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.schres.2017.09.026","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T16:18:36Z","timestamp":1506701916000},"page":"495-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders"],"prefix":"10.1016","volume":"195","author":[{"given":"Kristine","family":"R\u00f8mer Thomsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Thylstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Mulbjerg","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads Uffe","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.schres.2017.09.026_bb0005","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1176\/appi.ps.201200440","article-title":"Relationship between relapse and hospitalization in first-episode psychosis","volume":"64","author":"Addington","year":"2013","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/ADT.0000000000000086","article-title":"Cannabis and amphetamine-type stimulant-induced psychoses: a systematic overview","volume":"15","author":"Alharbi","year":"2016","journal-title":"Addict. Disord. Their Treat."},{"issue":"8574","key":"10.1016\/j.schres.2017.09.026_bb0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2017.09.026_bb0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2017.09.026_bb0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","article-title":"Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10year follow-up study in the OPUS cohort","volume":"168","author":"Austin","year":"2015","journal-title":"Schizophr. Res."},{"issue":"13","key":"10.1016\/j.schres.2017.09.026_bb0030","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2174\/13816128113199990432","article-title":"Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review","volume":"20","author":"Batalla","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.schres.2017.09.026_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"issue":"1","key":"10.1016\/j.schres.2017.09.026_bb0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2008.12.014","article-title":"Dissecting components of reward: \u2018liking\u2019, \u2018wanting\u2019, and learning","volume":"9","author":"Berridge","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7629","key":"10.1016\/j.schres.2017.09.026_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of Delta9-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"issue":"Suppl. 7","key":"10.1016\/j.schres.2017.09.026_bb0050","first-page":"5","article-title":"Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness","volume":"67","author":"Buckley","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"21","key":"10.1016\/j.schres.2017.09.026_bb0055","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1523\/JNEUROSCI.1033-13.2013","article-title":"Amphetamine mechanisms and actions at the dopamine terminal revisited","volume":"33","author":"Calipari","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2017.09.026_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/NDT.S2178","article-title":"Drug and alcohol misuse in first episode psychosis: an observational study","volume":"4","author":"Crebbin","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2017.09.026_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","article-title":"Stimulant psychosis: systematic review","volume":"185","author":"Curran","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.09.026_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.schres.2017.09.026_bb0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0924-9338(99)00234-5","article-title":"Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?","volume":"14","author":"Dalmau","year":"1999","journal-title":"Eur. Psychiatry"},{"issue":"14","key":"10.1016\/j.schres.2017.09.026_bb0080","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2017.09.026_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D'Souza","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2017.09.026_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.forsciint.2017.01.007","article-title":"A study of cannabis potency in France over a 25years period (1992\u20132016)","volume":"272","author":"Dujourdy","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"446","key":"10.1016\/j.schres.2017.09.026_bb0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbp126","article-title":"Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use","volume":"37","author":"Gonzalez-Pinto","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamapsychiatry.2013.3726","article-title":"Comorbidity of severe psychotic disorders with measures of substance use","volume":"71","author":"Hartz","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.schres.2017.09.026_bb0115","first-page":"15","article-title":"Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome","volume":"6","author":"Hegelstad","year":"2012","journal-title":"Early Interv. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.09.026_bb0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.09.026_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr. Res."},{"issue":"20","key":"10.1016\/j.schres.2017.09.026_bb0130","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2017.09.026_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/schbul\/16.1.97","article-title":"Dopaminergic mechanisms in idiopathic and drug-induced psychoses","volume":"16","author":"Lieberman","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.09.026_bb0140","series-title":"Det illegale stofmarked i \u00c5rhus: Status og udvikling over 10 \u00e5r [The Illegal Drug Market in Aarhus: Status and Development Over 10years]","author":"Lindholst","year":"2008"},{"key":"10.1016\/j.schres.2017.09.026_bb0145","series-title":"Narkotika p\u00e5 gadeplan 2014 [Street Drugs 2014]","author":"Lindholst","year":"2015"},{"key":"10.1016\/j.schres.2017.09.026_bb0150","series-title":"Narkotika p\u00e5 gadeplan 2016 [Street Drugs 2016]","author":"Lindholst","year":"2017"},{"issue":"11","key":"10.1016\/j.schres.2017.09.026_bb0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291707002656","article-title":"Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service","volume":"38","author":"Malla","year":"2008","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.schres.2017.09.026_bb0160","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1017\/S0033291714000191","article-title":"Prognosis of schizophrenia in persons with and without a history of cannabis use","volume":"44","author":"Manrique-Garcia","year":"2014","journal-title":"Psychol. Med."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.09.026_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(02)00523-6","article-title":"Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences","volume":"67","author":"Margolese","year":"2004","journal-title":"Schizophr. Res."},{"issue":"32","key":"10.1016\/j.schres.2017.09.026_bb0170","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.schres.2017.09.026_bb0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis","volume":"192","author":"Morgan","year":"2008","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2017.09.026_bb0180","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2017.09.026_bb0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish Psychiatric Central Research Register","volume":"39","author":"Mors","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"6","key":"10.1016\/j.schres.2017.09.026_bb0190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4603(98)00073-2","article-title":"Dual diagnosis: a review of etiological theories","volume":"23","author":"Mueser","year":"1998","journal-title":"Addict. Behav."},{"issue":"9","key":"10.1016\/j.schres.2017.09.026_bb0195","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/0004867412440192","article-title":"Does giving up substance use work for patients with psychosis? A systematic meta-analysis","volume":"46","author":"Mullin","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.09.026_bb0200","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, E., and Medicine","year":"2017"},{"issue":"12","key":"10.1016\/j.schres.2017.09.026_bb0205","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/add.13082","article-title":"Potency trends of Delta9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005\u201315","volume":"110","author":"Niesink","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.schres.2017.09.026_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2017.09.026_bb0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13546800802264330","article-title":"Working memory and depressive symptoms in patients with schizophrenia and substance use disorders","volume":"13","author":"Potvin","year":"2008","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.schres.2017.09.026_bb0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neubiorev.2017.05.025","article-title":"Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior","volume":"80","author":"R\u00f8mer Thomsen","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08897077.2014.933726","article-title":"An international perspective and review of cocaine-induced psychosis: a call to action","volume":"35","author":"Roncero","year":"2014","journal-title":"Subst. Abus."},{"issue":"10","key":"10.1016\/j.schres.2017.09.026_bb0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.09.026_bb0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13651501.2012.687452","article-title":"Factors associated with relapse in patients with schizophrenia","volume":"17","author":"San","year":"2013","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.09.026_bb0240","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.schres.2011.04.011","article-title":"The impact of substance use disorders on the course of schizophrenia-A 15-year follow-up study dual diagnosis over 15 years","volume":"130","author":"Schmidt","year":"2011","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2017.09.026_bb0250","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2years after onset of psychosis: an observational study","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.09.026_bb0255","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","article-title":"How addictive drugs disrupt presynaptic dopamine neurotransmission","volume":"69","author":"Sulzer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.schres.2017.09.026_bb0260","series-title":"Registry of Drug Abusers Undergoing Treatment","author":"The National Board of Social Services and the Ministry of Social Affairs","year":"2014"},{"issue":"1","key":"10.1016\/j.schres.2017.09.026_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00127-015-1104-4","article-title":"Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study","volume":"51","author":"Toftdahl","year":"2016","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2017.09.026_bb0270","series-title":"World Drug Report 2014","author":"United Nations Office on Drugs and Crime","year":"2014"},{"key":"10.1016\/j.schres.2017.09.026_bb0275","first-page":"16","article-title":"Psychosis associated with acute recreational drug toxicity: a European case series","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2017.09.026_bb0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.105.017236","article-title":"Substance misuse in first-episode psychosis: 15-month prospective follow-up study","volume":"189","author":"Wade","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.09.026_bb0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/schbul\/sbw179","article-title":"The effect of substance use on 10-year outcome in first-episode psychosis","volume":"43","author":"Weibell","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.schres.2017.09.026_bb0290","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1176\/ps.62.9.pss6209_1007","article-title":"Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment","volume":"62","author":"Wisdom","year":"2011","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2017.09.026_bb0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/dta.1690","article-title":"Cannabis potency in the Venice area (Italy): update 2013","volume":"7","author":"Zamengo","year":"2015","journal-title":"Drug Test. Anal."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417305881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417305881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T14:22:30Z","timestamp":1549376550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417305881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":59,"alternative-id":["S0920996417305881"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.09.026","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}